Cargando…
Merkel cell carcinoma in lymph nodes with and without primary origin
The prognosis of MCC with lymph node involvement was better in patients with an unknown than a known primary. Treatment with a uniform aggressive combined chemoradiation regimen, with or without lymphadenectomy, led to better survival rates than previously reported.[Image: see text]
Autores principales: | Fennig, Shlomit, Landman, Yosef, Brenner, Ronen, Billan, Salem, Fenig, Eyal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921907/ https://www.ncbi.nlm.nih.gov/pubmed/35128847 http://dx.doi.org/10.1002/cam4.4562 |
Ejemplares similares
-
Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma—A multicenter real‐world experience in Israel
por: Averbuch, Itamar, et al.
Publicado: (2023) -
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
por: Eroglu, Zeynep, et al.
Publicado: (2022) -
Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma
por: Zhu, Xiaoke, et al.
Publicado: (2020) -
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021) -
Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients
por: Wang, Yan, et al.
Publicado: (2018)